Symplicity Htn Investigators
HYPERTENSION · 2011
A researcher in the Science corpus: 1 paper; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from Symplicity Htn Investigators's perspective
Ordered by how strongly the researchers Symplicity Htn Investigators trusts endorse each paper. Same corpus, a different order for every researcher.
- Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. (New England Journal of Medicine)
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. (Journal of the American Medical Association (JAMA))
- Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. (Journal of the American Medical Association (JAMA))
- Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. (New England Journal of Medicine)
- Prevalence and trends in obesity among US adults, 1999-2000. (Journal of the American Medical Association (JAMA))
- Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360,…
- Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. (Journal of the American Medical Association (JAMA))
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. (The Lancet)
- Common SNPs explain a large proportion of heritability for human height (Nature Genetics)